Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway.

MLA

Zhang, Qin, et al. “Dexmedetomidine Inhibits Mitochondria Damage and Apoptosis of Enteric Glial Cells in Experimental Intestinal Ischemia/Reperfusion Injury via SIRT3-Dependent PINK1/HDAC3/P53 Pathway.” Journal of Translational Medicine, vol. 19, no. 1, Nov. 2021, p. 463. EBSCOhost, https://doi.org/10.1186/s12967-021-03027-6.

APA

Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K. (2021). Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway. Journal of Translational Medicine, 19(1), 463. https://doi.org/10.1186/s12967-021-03027-6

Chicago

Zhang, Qin, Xiao-Ming Liu, Qian Hu, Zheng-Ren Liu, Zhi-Yi Liu, Huai-Gen Zhang, Yuan-Lu Huang, Qiu-Hong Chen, Wen-Xiang Wang, and Xue-Kang Zhang. 2021. “Dexmedetomidine Inhibits Mitochondria Damage and Apoptosis of Enteric Glial Cells in Experimental Intestinal Ischemia/Reperfusion Injury via SIRT3-Dependent PINK1/HDAC3/P53 Pathway.” Journal of Translational Medicine 19 (1): 463. doi:10.1186/s12967-021-03027-6.